Colorado: Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases.
The medicine, LL-341070, improves the brain's ability to repair damaged myelin--the protective sheath that surrounds nerve fibers. Myelin damage is a hallmark of disorders such as MS, as well as a normal consequence of aging, and it frequently causes visual loss, loss of motor abilities, and cognitive decline.
